MEDIKATUS - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 151,057 | 185,345 | 272,985 | 217,821 | 295,616 | 233,188 | 206,445 | 178,074 |
| Profit before tax | - | - | - | - | - | - | -10,656 | -10,858 |
| Net profit | -4,894 | 6,856 | 76,432 | 6,264 | 27,445 | 5,848 | -10,656 | -10,858 |
| Equity | 38,983 | 45,838 | 122,270 | 128,534 | 155,978 | 143,826 | 133,171 | 122,312 |
| Liabilities | 11,182 | 28,859 | 24,198 | 31,282 | 20,088 | 13,184 | 8,347 | 19,309 |
| Non-current assets | 2,172 | 2,645 | 4,473 | 5,631 | 5,342 | 4,247 | 1,880 | 1,424 |
| Current assets | 35,882 | 64,704 | 139,399 | 149,292 | 169,622 | 151,863 | 138,655 | 139,199 |
| Total assets | 38,054 | 67,349 | 143,872 | 154,923 | 174,964 | 156,110 | 140,535 | 140,623 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 47,962 | 45,185 | 38,361 |
| Social insurance contributions | - | - | - | - | - | 12,894 | 1,761 | - |
|
Financial indicators
|
||||||||
| Revenue change y/y | +17.0% | +22.7% | +47.3% | -20.2% | +35.7% | -21.1% | -11.5% | -13.7% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -12.9% | 10.2% | 53.1% | 4.0% | 15.7% | 3.7% | -7.6% | -7.7% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -12.6% | 15.0% | 62.5% | 4.9% | 17.6% | 4.1% | -8.0% | -8.9% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -3.2% | 3.7% | 28.0% | 2.9% | 9.3% | 2.5% | -5.2% | -6.1% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | - | -5.2% | -6.1% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.3 | 0.6 | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.2 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 30,211 | 34,217 | 54,597 | 51,252 | 73,904 | 59,537 | 68,815 | 59,358 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
MEDIKATUS - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2022-12-16 | 2022-12-19 | 1.54 |
| 2022-11-21 | 2022-12-12 | 1.54 |
| 2022-11-17 | 2022-11-18 | 1.54 |
| 2022-10-31 | 2022-11-13 | 1.54 |
| 2022-09-16 | 2022-09-19 | 1023.97 |
MEDIKATUS - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-05-20 | 2026-05-20 | 2.52 |
| 2025-09-30 | 2025-09-30 | 6.14 |
| 2025-02-28 | 2025-03-12 | 0.06 |
| 2025-02-20 | 2025-02-24 | 21.04 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
MEDIKATUS, UAB (code 301635564) is a Private Limited Liability Company active in wholesale of perfume and cosmetics. In 2025, the company generated revenue of €178.1K, down from €206.4K in 2024 and €233.2K in 2023, showing a three-year decline in turnover. Net profit followed a weaker path: after a profit of €5.8K in 2023, the company posted losses of €10.7K in 2024 and €10.9K in 2025. The 2025 profit margin was -6.1%, compared with 2.5% in 2023 and -5.2% in 2024, indicating sustained pressure on profitability. Balance sheet size remained broadly stable at €140.6K in 2025, versus €140.5K in 2024 and €156.1K in 2023. Equity declined from €143.8K in 2023 to €122.3K in 2025, while liabilities increased to €19.3K from €8.3K in 2024. The equity ratio was 87.0%, debt-to-equity 0.16, and asset turnover 1.27x in 2025. Revenue per employee was €59.4K, with profit per employee at -€3.6K.